Comment by
Sailboatdream on Apr 29, 2022 11:31am
Good observation. As more experienced investors get involved with Sernova, they will have to up their game. Institutional investors don't go for fluff... or amateur moves. They will expect results. They will be demanding. This should help everyone.
Comment by
BioTeck on Apr 29, 2022 11:43am
I'd love to see the actual institutional ownership. My guess is that very little is held by institutions.
Comment by
Sailboatdream on Apr 29, 2022 12:41pm
You are correct Bio. But Phil and Chris have been courting them in the past few months as mentioned in AGM. Seems institutionals are waiting for the first announcement before jumping in. But if / when they do, PT and his team will need to sharpen their answers.
Comment by
MustangSalley on Apr 29, 2022 4:24pm
Problem is the news will come when markets are tanking and there is blood on the streets ..... then they will wonder why nobody reacted to the positive news...... timing the market and pr are not the strenghs of management . MS
Comment by
BioTeck on Apr 29, 2022 6:02pm
Can you remind me again what the strengths are? Oh right, printing themselves free shares and carrot dangling.
Comment by
Metalsguy1 on Apr 29, 2022 1:46pm
Biotek it is more likely that we will all be institutionalized for buying and holding this stock long before any institution takes a bite.
Comment by
MustangSalley on Apr 29, 2022 4:21pm
I totally agree with you Eken. Now getting another pr firm? Paying Ray Matthews, Chris , Life Sciences over $35 k US a month . No recognition by anybody . All they talk about is Vertex and Viacycte. Sva has another insulin independent patient (3 rd) and crickets . What's wrong with this picture? Why are they paying Ray Matthews for again? MS